Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-13 09:09 am Purchase | 13G | Altair Engineering Inc. ALTR | Matrix Capital Management Company LP | 12,430,000 20.900% | 196,826 (+1.61%) | View |
| 2024-11-13 09:04 am Sale | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | Matrix Capital Management Company LP | 226,089,090 14.730% | -7,756,020 (-3.32%) | View |
| 2024-11-13 09:00 am Sale | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | Matrix Capital Management Company LP | 650,000 0.440% | -10,922,590 (-94.38%) | View |
| 2024-02-13 4:15 pm Purchase | 13G | Altair Engineering Inc. ALTR | Matrix Capital Management Company LP | 12,233,174 22.400% | 1,362,174 (+12.53%) | View |
| 2023-11-09 4:34 pm Purchase | 13D | Aura Biosciences Inc. AURA | Matrix Capital Management Company LP | 6,922,870 14.100% | 1,560,000 (+29.09%) | View |
| 2023-07-10 4:15 pm Unchanged | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | Matrix Capital Management Company LP | 233,845,110 17.290% | 0 (Unchanged) | View |
| 2023-06-20 4:30 pm Purchase | 13D | Zentalis Pharmaceuticals Inc. ZNTL | Matrix Capital Management Company LP | 13,959,973 19.810% | 4,760,000 (+51.74%) | View |
| 2023-02-13 4:07 pm Sale | 13G | NEW RELIC INC. NEWR | Matrix Capital Management Company LP | 0 0.000% | -5,000,000 (Position Closed) | View |
| 2023-02-13 4:06 pm Sale | 13G | ForgeRock Inc. FORG | Matrix Capital Management Company LP | 0 0.000% | -1,000,000 (Position Closed) | View |
| 2023-02-13 4:05 pm Purchase | 13G | Altair Engineering Inc. ALTR | Matrix Capital Management Company LP | 10,871,000 20.750% | 2,271,000 (+26.41%) | View |
| 2023-02-13 4:04 pm Sale | 13G | PERIMETER SOLUTIONS INC PRM | Matrix Capital Management Company LP | 8,587,500 5.430% | -3,875,000 (-31.09%) | View |
| 2022-12-07 4:30 pm Purchase | 13D | Aura Biosciences Inc. AURA | Matrix Capital Management Company LP | 5,362,870 14.500% | 1,250,000 (+30.39%) | View |
| 2022-06-03 10:52 am Purchase | 13D | Zentalis Pharmaceuticals Inc. ZNTL | Matrix Capital Management Company LP | 9,199,973 16.450% | 4,850,694 (+111.53%) | View |
| 2022-02-18 4:05 pm Purchase | 13G | NEW RELIC INC. NEWR | Matrix Capital Management Company LP | 5,000,000 7.640% | 1,437,500 (+40.35%) | View |
| 2022-02-14 12:05 pm Purchase | 13G | Altair Engineering Inc. ALTR | Matrix Capital Management Company LP | 8,600,000 16.930% | 3,444,975 (+66.83%) | View |
| 2022-02-14 12:05 pm Sale | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | Matrix Capital Management Company LP | 11,572,590 8.200% | -1,542,500 (-11.76%) | View |
| 2022-02-14 12:03 pm Purchase | 13G | Zentalis Pharmaceuticals Inc. ZNTL | Matrix Capital Management Company LP | 4,349,279 9.600% | 527,540 (+13.80%) | View |
| 2022-02-14 12:02 pm Purchase | 13G | PERIMETER SOLUTIONS INC PRM | Matrix Capital Management Company LP | 12,462,500 7.690% | 12,462,500 (New Position) | View |
| 2022-02-14 12:01 pm Purchase | 13G | ForgeRock Inc. FORG | Matrix Capital Management Company LP | 1,000,000 7.910% | 1,000,000 (New Position) | View |
| 2022-02-14 12:01 pm Sale | 13G | NEW RELIC INC. NEWR | Matrix Capital Management Company LP | 3,562,500 5.450% | -1,437,500 (-28.75%) | View |